| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.31B | +4.7% | +27.5% |
| Cost of Revenue | $818.1M | +6.8% | +26.0% |
| Gross Profit | $1.49B | +3.6% | +28.3% |
| R&D Expense | $326.0M | +9.9% | +38.2% |
| SG&A Expense | $34.8M | +18.4% | +2.9% |
| Operating Income | $978.2M | -0.8% | +24.6% |
| Pre-tax Income | $1.08B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.33B | +4.5% | -26.7% |
| Accounts Receivable | $1.49B | -8.3% | +31.7% |
| Inventory | $2.16B | +4.7% | +21.8% |
| Current Assets | $15.18B | +12.5% | +39.6% |
| Total Assets | $18.05B | +9.2% | +40.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.11B | — | — |
| Capital Expenditures | $82.5M | — | — |
| Investing Cash Flow | -$2.58B | — | — |
| Financing Cash Flow | -$970.4M | — | — |
| Free Cash Flow | $3.03B | — | — |
| -0.3% |
| +22.0% |
| Income Tax | $224.1M | +17.1% | +66.0% |
| Net Income | $853.0M | -4.0% | +14.0% |
| EPS (Basic) | $0.68 | -4.2% | -71.4% |
| EPS (Diluted) | $0.67 | -4.3% | -71.2% |
| $4.67B |
| +15.2% |
| +91.7% |
| Total Liabilities | $6.14B | +9.0% | +70.6% |
| Stockholders' Equity | $11.91B | +9.2% | +28.8% |